No Data
SINOHEALTH HLDG: 2024 INTERIM REPORT
Zhongkang Holdings (02361): Wanchuan resigns as joint company secretary.
Zhongkang Holdings (02361) announced that Wanchuan has resigned from the position of co-company secretary of the company, effective September 1, 2024...
Hong Kong stock market anomaly | Zhongkang Holdings (02361) rose more than 10% at the close. Both revenue and profit achieved double-digit growth in the first half of the year, promoting the digital transformation of the health industry by the company.
China Health Holdings (02361) rose after the results, with the closing stock price up more than 10%, as of the time of publication, up 10.65%, at HKD 5.09.
Health industry digital transformation pioneer, Zhongkang Holdings (02361) continuously releases long-term value.
How will Zhongkang Holdings leverage research and development innovation to achieve value leap in the face of the current pressure and challenges in the pharmaceutical industry, and how will it seek new market opportunities?
Understanding the mid-term performance of China National HealthCare Holdings (02361) in 2024 with one picture
Understanding the mid-term performance of China National HealthCare Holdings (02361) in 2024 with one picture
Zhongkang Holdings (02361.HK) achieved revenue of 0.16 billion yuan in the first half of the year, an increase of approximately 10.1% year-on-year.
On August 28, GeLongHui announced that as of June 30, 2024, in the six months of the reporting period, benefited from the continuous development of the industrial cooperation network and the continuous innovation of products and business, the customer base and prices of smart retail cloud and saas products have risen, thereby driving further improvement in the group's revenue scale and operational efficiency, with revenue of approximately RMB 0.16 billion, a year-on-year growth of approximately 10.1%; leading big data processing technology and a continuously solidified data platform construction have greatly improved technological efficiency, thus driving the continuous optimization of the group's cost efficiency and nurturing
No Data
No Data